期刊文献+

Proteomic analysis of human serum from diabetic retinopathy 被引量:4

Proteomic analysis of human serum from diabetic retinopathy
下载PDF
导出
摘要 AIM: To establish and compare serum proteomic of diabetic retinopathy (DR) patients in various phases and discuss pathogenesis of DR so as to find out possible serum specific molecular markers for early diagnosis of DR. METHODS: Thirty-two subjects were divided into four groups: one group of eight type 2 diabetes mellitus (T2DM) patients without apparent DR (No-DR, NDR), one group of eight T2DM patients with non-proliferative diabetic retinopathy (NPDR), one group of eight T2DM patients with proliferative diabetic retinopathy(PDR) and one group of eight healthy volunteer participants. Two dimensional fluorescence difference gel electrophoresis (2D-DIGE) was applied to establish differential protein expression profiles in four groups. Matrix-assisted laser desorption/ionization time of flight tandem mass spectrometry (MALDI-TOF-TOF MS) was applied to identify mass spectrometry of differential proteins and analyze follow-up bioinformatics. RESULTS: 2D-DIGE maps of serum protein were satisfactory obtained from NDR, NPDR, PDR and normal control groups. Twenty-six different proteins spots were screened(the volume ratio was > 1.5 based on DeCyder software analysis). Twenty-four of them were verified and two of them were not. Fifteen proteins were verified. Most of them were high-abundant proteins in serum. The four relatively low-abundant ones were beta 2-glycoprotein I (beta (2)-GPI), alpha2-HS-glycoprotein (AHSG), alpha1-acid glycoprotein (alpha(1)-AGP) and apolipoprotein A-1 (apo A-1). beta (2)-GPI expression was gradually increased in the development of DR but unrelated to the severity of DR. The volume ratio of beta (2)-GPI is 1.54, 2.43, and 2.84 in NDR, NPDR and PDR group respectively compared with normal control group. CONCLUSION: Serum proteomic analysis of 2D-DIGE combined with MALDI-TOF-TOF MS is feasible to be applied in the study of DR. 13 2-GPI probably takes part in the process of DR occurrence and development and it could be a candidate biomarker on DR diagnosis in early phase. AIM: To establish and compare serum proteomic of diabetic retinopathy (DR) patients in various phases and discuss pathogenesis of DR so as to find out possible serum specific molecular markers for early diagnosis of DR. METHODS: Thirty-two subjects were divided into four groups: one group of eight type 2 diabetes mellitus (T2DM) patients without apparent DR (No-DR, NDR), one group of eight T2DM patients with non-proliferative diabetic retinopathy (NPDR), one group of eight T2DM patients with proliferative diabetic retinopathy(PDR) and one group of eight healthy volunteer participants. Two dimensional fluorescence difference gel electrophoresis (2D-DIGE) was applied to establish differential protein expression profiles in four groups. Matrix-assisted laser desorption/ionization time of flight tandem mass spectrometry (MALDI-TOF-TOF MS) was applied to identify mass spectrometry of differential proteins and analyze follow-up bioinformatics. RESULTS: 2D-DIGE maps of serum protein were satisfactory obtained from NDR, NPDR, PDR and normal control groups. Twenty-six different proteins spots were screened(the volume ratio was > 1.5 based on DeCyder software analysis). Twenty-four of them were verified and two of them were not. Fifteen proteins were verified. Most of them were high-abundant proteins in serum. The four relatively low-abundant ones were beta 2-glycoprotein I (beta (2)-GPI), alpha2-HS-glycoprotein (AHSG), alpha1-acid glycoprotein (alpha(1)-AGP) and apolipoprotein A-1 (apo A-1). beta (2)-GPI expression was gradually increased in the development of DR but unrelated to the severity of DR. The volume ratio of beta (2)-GPI is 1.54, 2.43, and 2.84 in NDR, NPDR and PDR group respectively compared with normal control group. CONCLUSION: Serum proteomic analysis of 2D-DIGE combined with MALDI-TOF-TOF MS is feasible to be applied in the study of DR. 13 2-GPI probably takes part in the process of DR occurrence and development and it could be a candidate biomarker on DR diagnosis in early phase.
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2011年第6期616-622,共7页 国际眼科杂志(英文版)
基金 Supported by Natural Science Fund for Colleges and Universities in Anhui Province, China (No.KJ2007B208)
关键词 diabetic retinopathy difference gel electrophoresis β2-glycoprotein I PROTEOMICS SERUM type 2 diabetes diabetic retinopathy difference gel electrophoresis β2-glycoprotein I proteomics serum type 2 diabetes
  • 相关文献

参考文献22

  • 1M. García-Ramírez,F. Canals,C. Hernández,N. Colomé,C. Ferrer,E. Carrasco,J. García-Arumí,R. Simó.Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy[J]. Diabetologia . 2007 (6)
  • 2M. S. Christiansen,E. Hommel,E. Magid,B. Feldt-Rasmussen.Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up[J]. Diabetologia . 2005 (2)
  • 3Kempen JH,O’’Colmain BJ,Leske MC,Haffner SM,Klein R,Moss SE,Taylo HR,Hamman RF.The prevalence of diabetic retinopathy among adults in the United States. Archives of Ophthalmology . 2004
  • 4Cheung AK,Fung MK,Lo AC,Lam TT,So KF,Chung SS,Chung SK.Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes . 2005
  • 5Moore TC,Moore JE,Kaji Y,Frizzell N,Usui T,Poulaki V,Campbell IL,Stit AW,Gardiner TA,Archer DB,Adamis AP.The role of advanced glycation end products in retinal microvascular leukostasis. Investigative Opthalmology and Visual Science . 2003
  • 6Liu S,Bai S,Qin Z,Yang Y,Cui Y,Qin Y.Quantitative proteomic analysis o the cerebrospinal fluid of patients with multiple sclerosis. Journal of cellular andmolecular medicine . 2009
  • 7Rao PV,Lu X,Standley M,Pattee P,Neelima G,Girisesh G,Dakshinamurthy KV,Roberts CT,Jr,Nagalla SR.Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care . 2007
  • 8Ahn BY,Song ES,Cho YJ,Kwon OW,Kim JK,Lee NG.Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis. Proteomics . 2006
  • 9Kim T,Kim SJ,Kim K,Kang UB,Lee C,Park KS,Yu HG,Kim Y.Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics . 2007
  • 10Garbis S,Lubec G,Fountoulakis M.Limitations of current proteomics technologies. Journal of Chromatography . 2005

共引文献4

同被引文献6

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部